04 · Product & medtech
Senior Product Owner Software
I own the software side of FibroScan, a non-invasive medical device for chronic liver disease used by clinicians in more than 100 countries: vision, roadmap and backlog, inside a full medical-device quality system.
At Echosens I turn clinical, user and business needs into a clear product direction, and prioritise with R&D, clinical, regulatory, quality and market teams so that what ships is coherent, usable and compliant. The role brings together what I practised across robotics and assistive technology: framing products for regulated systems, keeping the user at the centre of technical decisions, and steering multidisciplinary teams from discovery to delivery.
- Ownership
- Medical-device software vision, roadmap, backlog and release scope.
- Discovery
- With clinicians, users and market teams, translated into specifications engineers can build.
- Regulation
- Risk management, usability engineering and the software lifecycle as part of the product.
- Alignment
- Between R&D, clinical, regulatory, quality and business stakeholders.
Working in a regulated product
Medical-device software is shaped by a small set of frameworks: IEC 62304 for the software lifecycle, ISO 14971 for risk management, IEC 62366-1 for usability engineering, ISO 13485 for the quality system and the EU MDR for market access. For a product owner they are not paperwork at the end. They decide how a backlog is cut, what a release can contain, which user needs must be traced to a verified requirement and when a usability finding blocks a ship date.
I met these frameworks on Extender, developed in a medical-device context with Orthopus, and built Bloom’s safety and usability decisions around risk: a latched STOP, one command owner per session, an audit log and a review checklist before a screen reaches a user.
Why medtech
Devices that change a care pathway need product decisions grounded in clinical reality, not only in technology. Assistive robotics in a medical-device context taught me to design for patients, clinicians and regulation at once, and I keep contributing to assistive technology through open source and the Paris Cybathlétique Club.